These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 36311877)
1. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program. Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS Neurosci Behav Physiol; 2022; 52(6):836-841. PubMed ID: 36311877 [No Abstract] [Full Text] [Related]
2. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX]. Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707 [TBL] [Abstract][Full Text] [Related]
3. [The use of neurotropic therapy in young patients with postcovid syndrome]. Ivonina NA; Petrov KB Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):126-130. PubMed ID: 35394732 [TBL] [Abstract][Full Text] [Related]
4. [The result of prospective randomized study CITADEL - the efficacy and safety of drug cytoflavin in postcovid rehabilitation]. Putilina MV; Teplova NV; Bairova KI; Petrikeeva AE; Shabalina NI Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):45-51. PubMed ID: 34874654 [TBL] [Abstract][Full Text] [Related]
6. Correction of Mitochondrial Dysfunction in the Complex Rehabilitation of COVID-19 Patients. Tereshin AE; Kiryanova VV; Reshetnik DA Neurosci Behav Physiol; 2022; 52(4):511-514. PubMed ID: 35892008 [No Abstract] [Full Text] [Related]
7. Neurological Aspects of the Sequelae of COVID-19 in Children. Nemkova SA Neurosci Behav Physiol; 2022; 52(8):1169-1176. PubMed ID: 36817565 [TBL] [Abstract][Full Text] [Related]
8. [Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)]. Mashin VV; Belova LA; Kotova EY; Dolgova DR; Statenina AP; Belyaeva YK; Dergacheva AS; Israfilova RR Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12):34-41. PubMed ID: 38147380 [TBL] [Abstract][Full Text] [Related]
9. [A multicenter observation study of the efficacy of cortexin and recognan (citicoline) in the treatment of cognitive impairments in chronic cerebrovascular pathology]. Belova LA; Mashin VV; Dudikov EM; Belov DV; Krupennikov AA Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2):35-38. PubMed ID: 30874524 [TBL] [Abstract][Full Text] [Related]
10. [Neurological disorders in the postcovid period]. Fedin AI Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):31-37. PubMed ID: 36279226 [TBL] [Abstract][Full Text] [Related]
11. [Neurological aspects of the consequences of COVID-19 in children]. Nemkova SA Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):23-30. PubMed ID: 35485061 [TBL] [Abstract][Full Text] [Related]
12. [An open clinical trial of cortexin in treatment of brain ischemia]. Mashin VV; Belova LA; Chaplanova OI; Khusnullina AF; Manasian AM Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):49-52. PubMed ID: 25403301 [TBL] [Abstract][Full Text] [Related]
13. [Post-COVID syndrome in the neurological practice]. Cherdak MA; Mkhitaryan EA Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):124-129. PubMed ID: 37490677 [TBL] [Abstract][Full Text] [Related]
14. [Prospects and possibilities for the treatment of patients with long COVID-19 syndrome]. Tanashyan MM; Raskurazhev AA; Kuznetsova PI; Bely PA; Zaslavskaya KI Ter Arkh; 2022 Dec; 94(11):1285-1293. PubMed ID: 37167167 [TBL] [Abstract][Full Text] [Related]
15. [Neurological manifestations of postcovid syndrome]. Kamchatnov PR; Cheremin RA; Skipetrova LA; Chugunov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):7-15. PubMed ID: 35394713 [TBL] [Abstract][Full Text] [Related]
16. [Post-COVID-19 asthenic syndrome]. Zolotovskaia IA; Shatskaia PR; Davydkin IL; Shavlovskaya OA Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(4):25-30. PubMed ID: 34037351 [TBL] [Abstract][Full Text] [Related]
17. [Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)]. Fedin AI; Belskaya GN; Kurushina OV; Kovalchuk VV; Starych EV; Chichanovskaya LV; Baranova OA Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):35-42. PubMed ID: 30335070 [TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and metabolic therapy of fatigue in the acute and early recovery periods of ischemic stroke]. Tynterova AM; Belousova YD; Reznik EY Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3. Vyp. 2):94-100. PubMed ID: 36950826 [TBL] [Abstract][Full Text] [Related]
19. [Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children]. Zykov VP; Serebrennikova EB; Panchenko TN; Sycheva YB; Presnyakova SN; Mazur EL; Salova MN; Golubeva ES; Khromova SK Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3):27-31. PubMed ID: 29652302 [TBL] [Abstract][Full Text] [Related]
20. [Asthenic post-COVID syndrome]. Khaibullina DK; Maksimov YN Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):61-69. PubMed ID: 36946399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]